Functional Organization Chart
R&D Functional Organization Chart
Zheming Gu,General Manager,XBL-China. Dr.Gu is the Vice President and Global Head of Biotransformations and Drug Metabolism at XenoBiotic Laboratories, Inc. (XBL). He manages and directs drug metabolism and bioanalysis of various types of molecules from drug discovery to development. Dr. Gu received his Bachelor's degree in Pharmacy in 1982, and obtained his Ph.D. in Pharmacognosy from Beijing Medical University in 1986.From 1989.1.-1990.1, Dr.Gu obtained a World Health Organization (WHO) scholarship and worked as visiting researcher at Toyama Medical and Pharmaceutical University, Japan, for a year.He was promoted to a full professor in China in 1992. He then went to the USA and pursued his research (as the head post-doctor) in Natural Product Chemistry at Purdue University for three years. He joined XBL in 1994, and has spent almost 17 years there, dealing with various drug discovery and development projects, mainly in biotransformations and drug metabolism, bioanalysis, drug impurity and degradation product identification, and drug formulation analysis analysis.To complete his tasks at XBL, he leads his team utilizing all types of HPLC/radio-chromatography, LC/MS/MS, and NMR instruments, and completed over 100 research projects in the past 5 years.He has published over 70 articles or book chapters in various scientific fields.
Dennis P Heller, Ph.D. Global Marketing,XBL. Dr. Heller is Vice President of Drug Development for XenoBiotic Laboratories (XBL) Inc. In his current role, Dr. Heller is responsible for Business Development, Marketing, Client management, and project management support. On the scientific side, Dr. Heller has been involved with human radiolabel DMPK and biodistribution imaging studies, dosimetry and PK analysis for over 15 years.Prior to joining XBL in 2004, Dr. Heller was VP, Business Development for Pharmaceutical Profiles, a UK CRO that utilized gamma scintigraphy in drug development. From 1996-2000, Dr. Heller was Associate Director of Imaging and Radiopharmaceuticals for MDS Pharma Services (formerly Phoenix International Life Sciences) where he conducted many human radiolabel mass balance studies. Prior to moving to industry, Dr. Heller was Assistant Professor, Department of Radiology, Division of Radiation Oncology at the University of Cincinnati, Ohio where he taught graduate courses in radiation biology and conducted research into the mechanisms of radiation resistance of cancer cells.Dr. Heller received his B.Sc. in Physics from the University of Waterloo, M.Sc. in Medical Physics from the University of Manitoba, and Ph.D. in Medical Physics/Radiation Biology from Carleton University all in Canada.